Founded in 1999, Medicines Evaluation Unit, classified under reg no. 03779957 is an active company. Currently registered at The Langley Building, Southmoor M23 9QZ, Manchester the company has been in the business for 25 years. Its financial year was closed on Sunday 31st March and its latest financial statement was filed on 31st March 2022.
At the moment there are 7 directors in the the firm, namely Elizabeth B., Jorgen V. and Ashley W. and others. In addition one secretary - David R. - is with the company. At the moment there are a few former directors listed by the firm. Similarly, the firm lists a few former secretaries. The full list of both former directors and former secretaries might be found in the table below.
| Office Address | The Langley Building, Southmoor |
| Office Address2 | Road, Wythenshawe |
| Town | Manchester |
| Post code | M23 9QZ |
| Country of origin | United Kingdom |
| Registration Number | 03779957 |
| Date of Incorporation | Fri, 28th May 1999 |
| Industry | Other research and experimental development on natural sciences and engineering |
| End of financial Year | 31st March |
| Company age | 25 years old |
| Account next due date | Sun, 31st Dec 2023 (150 days after) |
| Account last made up date | Thu, 31st Mar 2022 |
| Next confirmation statement due date | Tue, 11th Jun 2024 (2024-06-11) |
| Last confirmation statement dated | Sun, 28th May 2023 |
Position: Director
Appointed: 23 January 2024
Position: Director
Appointed: 19 December 2018
Position: Director
Appointed: 16 November 2015
Position: Director
Appointed: 16 November 2015
Position: Director
Appointed: 20 December 2004
Position: Director
Appointed: 08 September 2003
Position: Secretary
Appointed: 21 May 2001
Position: Director
Appointed: 20 November 2000
The register of persons with significant control that own or have control over the company consists of 1 name. As we discovered, there is North West Lung Research Centre Charity from Manchester, England. This PSC is classified as "a charity" and has 75,01-100% shares. This PSC and has 75,01-100% shares.
North West Lung Research Centre Charity
Nwlc Southmoor Road, Manchester, M23 9LT, England
| Legal authority | Charities Act |
| Legal form | Charity |
| Notified on | 6 April 2016 |
| Nature of control: |
75,01-100% shares |
| Profit & Loss | |||||
|---|---|---|---|---|---|
| Accounts Information Date | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
| Balance Sheet | |||||
| Cash Bank On Hand | 11 235 072 | 7 676 670 | 11 879 257 | 12 612 851 | 16 627 503 |
| Current Assets | 13 484 932 | 11 609 235 | 15 336 430 | 18 919 861 | 23 842 949 |
| Debtors | 2 249 860 | 3 932 565 | 3 457 173 | 6 307 010 | 7 215 446 |
| Net Assets Liabilities | 16 523 402 | 18 455 518 | 22 086 762 | 26 283 526 | 30 226 961 |
| Other Debtors | 70 147 | 124 046 | 108 | 79 124 | |
| Property Plant Equipment | 4 546 815 | 4 583 283 | 4 372 213 | 4 203 099 | 4 150 986 |
| Other | |||||
| Audit Fees Expenses | 14 386 | 6 500 | 5 700 | 5 700 | 11 700 |
| Fees For Non-audit Services | 2 300 | 2 300 | 2 750 | ||
| Amount Specific Advance Or Credit Directors | 46 188 | ||||
| Amount Specific Advance Or Credit Made In Period Directors | 46 188 | ||||
| Company Contributions To Money Purchase Plans Directors | 13 240 | 6 581 | 14 562 | 19 320 | 32 960 |
| Director Remuneration | 282 223 | 324 496 | 313 182 | 388 331 | 387 070 |
| Number Directors Accruing Benefits Under Money Purchase Scheme | 1 | 1 | 1 | 1 | 1 |
| Accrued Liabilities Deferred Income | 1 093 128 | 602 279 | 1 353 598 | 2 554 539 | 3 559 133 |
| Accumulated Depreciation Impairment Property Plant Equipment | 2 162 826 | 2 386 607 | 2 635 285 | 2 876 531 | 3 119 363 |
| Additional Provisions Increase From New Provisions Recognised In Profit Or Loss | 63 059 | -21 580 | 28 960 | ||
| Administrative Expenses | 2 809 144 | 3 259 389 | 3 270 559 | 4 002 595 | 4 372 244 |
| Amounts Owed By Group Undertakings | 11 507 | 208 620 | 334 984 | 2 733 124 | 1 206 115 |
| Amounts Recoverable On Contracts | 1 183 329 | 550 548 | 829 574 | 1 199 956 | 2 593 265 |
| Applicable Tax Rate | 19 | 19 | 19 | 19 | 19 |
| Average Number Employees During Period | 120 | 136 | 122 | 140 | 162 |
| Bank Overdrafts | |||||
| Called Up Share Capital Not Paid | 110 916 | ||||
| Cash Cash Equivalents Cash Flow Value | 11 235 072 | 7 676 670 | 11 879 257 | 12 612 851 | |
| Cash Receipts From Government Grants | -442 226 | ||||
| Comprehensive Income Expense | 3 270 012 | 2 254 902 | 5 035 645 | 5 673 816 | 5 145 652 |
| Corporation Tax Recoverable | 210 000 | 477 898 | 497 898 | 625 431 | 823 281 |
| Cost Sales | 5 781 937 | 5 867 512 | 7 736 977 | 8 012 261 | 8 086 711 |
| Creditors | 1 508 345 | 921 331 | 1 567 723 | 3 057 919 | 3 786 641 |
| Current Tax For Period | -264 439 | -233 459 | -127 533 | -197 850 | |
| Deferred Tax Liabilities | 63 059 | 63 059 | 41 479 | 70 439 | |
| Depreciation Amortisation Expense | 166 340 | 223 781 | 248 678 | 241 246 | 242 833 |
| Depreciation Expense Property Plant Equipment | 166 340 | 223 781 | 248 678 | 241 246 | 242 832 |
| Disposals Property Plant Equipment | 2 750 | ||||
| Dividends Paid | 550 853 | 322 786 | 1 404 401 | 1 477 160 | 1 451 697 |
| Dividends Paid Classified As Financing Activities | -550 853 | -322 786 | -1 404 401 | -1 477 160 | -1 451 697 |
| Dividends Paid On Shares | 550 853 | 322 786 | 1 404 401 | 1 477 160 | 1 451 697 |
| Dividends Paid On Shares Interim | 150 000 | 171 000 | 190 407 | 274 365 | 351 697 |
| Dividends Received Classified As Investing Activities | -6 267 | -75 618 | -90 188 | -123 714 | |
| Fixed Assets | 4 546 815 | 7 830 673 | 8 381 114 | 10 463 063 | 10 241 092 |
| Further Item Cash Flow From Used In Operating Activities Component Total Net Cash Flows From Used In Operating Activities | 442 226 | ||||
| Further Item Interest Expense Component Total Interest Expense | 23 128 | 11 522 | 192 | ||
| Further Item Proceeds From Sales Other Long-term Assets Classified As Investing Activities Component Corresponding Total | -614 021 | -1 469 504 | -1 281 001 | -1 988 224 | |
| Future Minimum Lease Payments Under Non-cancellable Operating Leases | 38 010 | 92 140 | 104 437 | 113 737 | 108 985 |
| Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss | -3 536 | ||||
| Gain Loss In Cash Flows From Change In Creditors Trade Other Payables | 149 247 | -587 014 | 646 392 | 1 490 195 | 728 723 |
| Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables | 1 354 839 | -1 414 807 | 495 392 | -2 722 303 | -396 380 |
| Gain Loss On Disposal Assets Income Statement Subtotal | -11 411 | 205 365 | 51 486 | -68 351 | |
| Gain Loss On Disposals Property Plant Equipment | -11 411 | 205 365 | 51 486 | -68 351 | |
| Gross Profit Loss | 5 872 186 | 5 721 280 | 6 972 400 | 9 135 251 | 9 487 039 |
| Income From Other Fixed Asset Investments | 6 267 | 75 618 | 90 188 | 123 714 | |
| Income Taxes Paid Refund Classified As Operating Activities | 279 189 | 213 459 | |||
| Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation | 3 883 861 | -3 558 402 | 4 202 587 | 733 594 | 4 014 652 |
| Increase Decrease In Current Tax From Adjustment For Prior Periods | -84 443 | -3 459 | |||
| Increase From Depreciation Charge For Year Property Plant Equipment | 223 781 | 248 678 | 241 246 | 242 832 | |
| Interest Paid Classified As Operating Activities | -23 128 | -11 522 | -192 | ||
| Interest Payable Similar Charges Finance Costs | 23 128 | 11 522 | 192 | ||
| Investments Fixed Assets | 3 247 390 | 4 008 901 | 6 259 964 | 6 090 106 | |
| Issue Equity Instruments | 108 | 249 480 | |||
| Key Management Personnel Compensation Total | 631 817 | 829 476 | 925 806 | ||
| Net Cash Flows From Used In Financing Activities | 957 799 | 322 786 | 1 404 401 | 1 477 052 | 1 516 425 |
| Net Cash Flows From Used In Investing Activities | 147 869 | 3 919 356 | -64 557 | 1 930 662 | 227 245 |
| Net Cash Flows From Used In Operating Activities | -4 989 529 | -683 740 | -5 542 431 | -4 141 308 | -5 758 322 |
| Net Cash Generated From Operations | -4 733 468 | -695 262 | -4 886 938 | -4 141 308 | -5 758 322 |
| Net Current Assets Liabilities | 11 976 587 | 10 687 904 | 13 768 707 | 15 861 942 | 20 056 308 |
| Net Interest Received Paid Classified As Investing Activities | -20 098 | -30 596 | -17 044 | -40 777 | -74 675 |
| Nominal Value Shares Issued Specific Share Issue | 1 | ||||
| Number Shares Issued But Not Fully Paid | 108 | ||||
| Number Shares Issued Fully Paid | 39 | 39 | 108 | 39 | |
| Operating Profit Loss | 3 063 042 | 2 461 891 | 4 144 067 | 5 183 656 | 5 114 795 |
| Other Deferred Tax Expense Credit | 63 059 | -21 580 | 28 960 | ||
| Other Interest Receivable Similar Income Finance Income | 20 098 | 30 596 | 17 044 | 40 777 | 74 675 |
| Other Investments Other Than Loans | -437 169 | 565 649 | 210 082 | -336 422 | |
| Other Operating Income Format1 | 442 226 | 51 000 | |||
| Other Taxation Social Security Payable | 228 510 | 105 858 | 111 746 | 126 025 | 47 783 |
| Par Value Share | 1 | 1 | 1 | 1 | |
| Payments To Redeem Own Shares | 138 564 | ||||
| Pension Other Post-employment Benefit Costs Other Pension Costs | 155 273 | 188 283 | 171 705 | 192 732 | 219 355 |
| Prepayments Accrued Income | 8 800 | 40 850 | 4 400 | 12 830 | 13 031 |
| Proceeds From Issuing Shares | -108 | 110 916 | |||
| Proceeds From Sales Property Plant Equipment | -2 750 | ||||
| Profit Loss | 3 270 012 | 2 254 902 | 5 035 645 | 5 673 816 | 5 145 652 |
| Profit Loss On Ordinary Activities Before Tax | 3 060 012 | 2 050 063 | 4 802 186 | 5 524 703 | 4 976 762 |
| Property Plant Equipment Gross Cost | 6 709 641 | 6 969 890 | 7 007 498 | 7 079 630 | 7 270 349 |
| Provisions | 63 059 | 63 059 | 41 479 | 70 439 | |
| Provisions For Liabilities Balance Sheet Subtotal | 63 059 | 63 059 | 41 479 | 70 439 | |
| Purchase Property Plant Equipment | -167 967 | -260 249 | -37 608 | -74 882 | -190 719 |
| Social Security Costs | 385 470 | 496 454 | 431 766 | 522 226 | 650 043 |
| Staff Costs Employee Benefits Expense | 4 695 811 | 5 247 826 | 5 071 564 | 6 003 201 | 6 731 693 |
| Tax Decrease Increase From Effect Revenue Exempt From Taxation | 1 191 | 71 796 | 47 269 | ||
| Tax Expense Credit Applicable Tax Rate | 581 402 | 389 512 | 912 415 | 1 049 694 | 945 585 |
| Tax Increase Decrease From Effect Capital Allowances Depreciation | 3 020 | -6 507 | 38 671 | 17 079 | 2 378 |
| Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss | 83 062 | 63 934 | |||
| Tax Tax Credit On Profit Or Loss On Ordinary Activities | -210 000 | -204 839 | -233 459 | -149 113 | -168 890 |
| Total Additions Including From Business Combinations Property Plant Equipment | 260 249 | 37 608 | 74 882 | 190 719 | |
| Total Assets Less Current Liabilities | 16 523 402 | 18 518 577 | 22 149 821 | 26 325 005 | 30 297 400 |
| Total Current Tax Expense Credit | -210 000 | -267 898 | -233 459 | ||
| Total Operating Lease Payments | 42 031 | 37 674 | 47 173 | 47 841 | 51 314 |
| Trade Creditors Trade Payables | 186 707 | 213 194 | 102 379 | 32 379 | 11 594 |
| Trade Debtors Trade Receivables | 836 224 | 2 584 502 | 1 666 271 | 1 735 561 | 2 297 338 |
| Turnover Revenue | 11 654 123 | 11 588 792 | 14 709 377 | 17 147 512 | 17 573 750 |
| Wages Salaries | 4 155 068 | 4 563 089 | 4 468 093 | 5 288 243 | 5 862 295 |
| Type | Category | Free download | |
|---|---|---|---|
| AA |
Full accounts for the period ending 31st March 2023 filed on: 21st, December 2023 |
accounts | Free Download (28 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy